SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)November 19, 2004
IMPAC Medical Systems, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 000-50082 | 94-3109238 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
100 West Evelyn Avenue, Mountain View, CA | 94041 | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code (650) 623-8800
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):
¨ | Written communication pursuant to Rule 425 under the Securities Ac (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. 13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition.
On November 19, 2004, IMPAC Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the third quarter ended June 30, 2004 and preliminary results for the fourth quarter and fiscal year ended September 30, 2004. A copy of the press release is attached as Exhibit 99.1.
Item 8.01 Other Events.
On November 19, 2004, the Company also announced that it had filed Form 10-Q/A for the fiscal quarters ended December 31, 2003 and March 31, 2004 and a Form 10-Q for the fiscal quarter ended June 30, 2004 with the Securities and Exchange Commission. A copy of the press release is attached as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(c) | Exhibits. |
99.1 | IMPAC Medical Systems, Inc. Press Release dated November 19, 2004. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
IMPAC MEDICAL SYSTEMS, INC. | ||
By: | /s/ KENDRA A. BORREGO | |
Kendra A. Borrego Chief Financial Officer |
Date: November 23, 2004
3
EXHIBIT INDEX
Exhibit No. | Description | |
99.1 | IMPAC Medical Systems, Inc. Press Release dated November 19, 2004. |